CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment.Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions.With our device as a platform approach we will be able to monitor, control and contain diseases worldwide.This device can be the difference between life and death, where the response time is crucial. Criam will increase medical efficiency of analysis in a blazing temporal space, which will save lives.
Total Funding: $2,100,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2016
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at CRIAM